Vaxart Inc VXRT:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/03/23 EST
1.07quote price arrow down-0.01 (-0.93%)
Volume
24,705
Close
1.08quote price arrow down-0.02 (-1.82%)
Volume
1,906,050
52 week range
0.73 - 5.43
Loading...
  • Open1.10
  • Day High1.13
  • Day Low1.07
  • Prev Close1.10
  • 52 Week High5.43
  • 52 Week High Date03/18/22
  • 52 Week Low0.73
  • 52 Week Low Date12/28/22

Key Stats

  • Market Cap141.749M
  • Shares Out131.25M
  • 10 Day Average Volume1.50M
  • Dividend-
  • Dividend Yield-
  • Beta0.77
  • YTD % Change12.39

KEY STATS

  • Open1.10
  • Day High1.13
  • Day Low1.07
  • Prev Close1.10
  • 52 Week High5.43
  • 52 Week High Date03/18/22
  • 52 Week Low0.73
  • 52 Week Low Date12/28/22
  • Market Cap141.749M
  • Shares Out131.25M
  • 10 Day Average Volume1.50M
  • Dividend-
  • Dividend Yield-
  • Beta0.77
  • YTD % Change12.39

RATIOS/PROFITABILITY

  • EPS (TTM)-0.83
  • P/E (TTM)-1.30
  • Fwd P/E (NTM)-0.97
  • EBITDA (TTM)-99.546M
  • ROE (TTM)-63.93%
  • Revenue (TTM)158,999.994
  • Gross Margin (TTM)5.38%
  • Net Margin (TTM)-65,788.68%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date02/22/2023(est)
  • Ex Div Date11/09/2012
  • Div Amount6.648
  • Split Date-
  • Split Factor-

Latest On Vaxart Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Vaxart, Inc. is a clinical-stage biotechnology company that is primarily focused on the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) oral vaccine platform. Its programs include tablet vaccines designed to protect against coronavirus, norovirus, seasonal influenza and respiratory syncytial virus (RSV), as well as a therapeutic vaccine for human papillomavirus (HPV). The Company’s product pipeline includes...
Todd Davis
Independent Chairman of the Board
Andrei Floroiu
President, Chief Executive Officer, Director
Phillip Lee
Chief Financial Officer, Chief Accounting Officer
Raymond Stapleton Jr., Ph.D.
Chief Technology Officer
Address
170 Harbor Way, Suite 300
South San Francisco, CA
94080
United States

Top Peers

SYMBOLLASTCHG%CHG
TNYA
Tenaya Therapeutics Inc
3.07-0.17-5.25%
TRVI
Trevi Therapeutics Inc
2.97+0.17+6.07%
KRON
Kronos Bio Inc
2.27-0.16-6.58%
GRCL
Gracell Biotechnologies Inc
2.11-0.02-0.94%
BCAB
Bioatla Inc
4.27+0.03+0.71%